open access

Vol 4, No 4 (2015)
Pharmaceutical news
Published online: 2015-10-16
Get Citation

Obesity and the risk of type 2 diabetes mellitus and certain types of cancer

Waldemar Karnafel, Barbara Możejko-Pastewka
DOI: 10.5603/DK.2015.0018
·
Diabetologia Kliniczna 2015;4(4):163-171.

open access

Vol 4, No 4 (2015)
Pharmaceutical news
Published online: 2015-10-16

Abstract

Obesity, type 2 diabetes mellitus and cancers are the most common chronic diseases. Data collected by world organizations for protection and promotion of health show a rapid increase in the prevalence of these illnesses over the last few decades. The rapid increase in prevalence of excess body weight globally is believed to be related to the growing proportion of people living in urban areas and the resulting changes in dietary and physical activity patterns.

The epidemic of overweight and obesity and the clear connection between raised BMI and many non-communicable diseases (such as cardiovascular diseases, type 2 diabetes, and cancers) make this issue a public health priority all over the world.

Estimates of future overweight and obesity prevalence assume that while keeping the current growth rate of prevalence, the numbers of people affected around the globe will rise to 2.16 billion for overweight and 1.12 billion for obesity in 2030. These numbers combined will constitute 58% of the world’s population. Considering the above, we should expect a proportional increase in prevalence of the most serious health consequences of overweight and obesity — type 2 diabetes mellitus and some cancers, including breast cancer in postmenopausal women, endometrial, colonic and renal cancers.

In this paper we discussed the available data on prevalence of overweight and obesity and analysed a causal relationship between excess body weight, type 2 diabetes mellitus and selected types of malignancies.

Abstract

Obesity, type 2 diabetes mellitus and cancers are the most common chronic diseases. Data collected by world organizations for protection and promotion of health show a rapid increase in the prevalence of these illnesses over the last few decades. The rapid increase in prevalence of excess body weight globally is believed to be related to the growing proportion of people living in urban areas and the resulting changes in dietary and physical activity patterns.

The epidemic of overweight and obesity and the clear connection between raised BMI and many non-communicable diseases (such as cardiovascular diseases, type 2 diabetes, and cancers) make this issue a public health priority all over the world.

Estimates of future overweight and obesity prevalence assume that while keeping the current growth rate of prevalence, the numbers of people affected around the globe will rise to 2.16 billion for overweight and 1.12 billion for obesity in 2030. These numbers combined will constitute 58% of the world’s population. Considering the above, we should expect a proportional increase in prevalence of the most serious health consequences of overweight and obesity — type 2 diabetes mellitus and some cancers, including breast cancer in postmenopausal women, endometrial, colonic and renal cancers.

In this paper we discussed the available data on prevalence of overweight and obesity and analysed a causal relationship between excess body weight, type 2 diabetes mellitus and selected types of malignancies.

Get Citation

Keywords

obesity, cancer, diabetes mellitus type 2, BMI

Supplementary Files (1)
Obesity and the risk of type 2 diabetes mellitus and certain types of cancer
Download
48KB
About this article
Title

Obesity and the risk of type 2 diabetes mellitus and certain types of cancer

Journal

Clinical Diabetology

Issue

Vol 4, No 4 (2015)

Pages

163-171

Published online

2015-10-16

DOI

10.5603/DK.2015.0018

Bibliographic record

Diabetologia Kliniczna 2015;4(4):163-171.

Keywords

obesity
cancer
diabetes mellitus type 2
BMI

Authors

Waldemar Karnafel
Barbara Możejko-Pastewka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl